Report summary
Reading File
Running Command
Here is the complete report summary for Mr. Hari Dev Kumar, 54-year-old male, sample collected on 13 June 2026.
Lab Report Summary - Hari Dev Kumar (54 M) | LCID: 261640281F
CRITICAL / ACTIONABLE FINDINGS
| Parameter | Result | Reference | Status |
|---|---|---|---|
| HbA1c | 12.0% | <6.5% | 🔴 Very HIGH - Poor diabetic control |
| Fasting Blood Sugar (FBS) | 275.54 mg/dL | 70-110 mg/dL | 🔴 Very HIGH |
| Estimated Avg Glucose (eAG) | 297.70 mg/dL | 0-140 mg/dL | 🔴 Very HIGH |
| Platelet Count | 60 × 10³/µL | 150-450 × 10³/µL | 🔴 LOW (Thrombocytopenia) |
| Triglycerides | 220.0 mg/dL | <150 mg/dL | 🟠 HIGH |
| eGFR | 80 mL/min/1.73m² | >90 | 🟡 MILDLY REDUCED (CKD G2) |
1. COMPLETE BLOOD COUNT (CBC) with ESR
| Parameter | Result | Reference | Flag |
|---|---|---|---|
| Haemoglobin | 14.6 g/dL | 12.0-16.0 | Normal |
| RBC Count | 5.67 million/mm³ | 4.00-5.50 | H - Slightly High |
| PCV/Hematocrit | 45.2% | 40-54% | Normal |
| MCV | 79.6 fL | 80-101 fL | L - Low (Microcytosis) |
| MCH | 25.8 pg | 27-34 pg | L - Low (Hypochromia) |
| MCHC | 32.4 g/dL | 32-36 | Normal |
| RDW-CV | 14.1% | 11-16% | Normal |
| WBC (Total Leucocytes) | 7.3 cell/cu.mm | 4-10 | Normal |
| Neutrophils | 44.7% | 40-80% | Normal |
| Lymphocytes | 45% | 20-40% | H - High (Relative Lymphocytosis) |
| Platelet Count | 60 × 10³/µL | 150-450 | 🔴 Very LOW |
| MPV | 12.1 fL | 6.5-12.0 | H - Slightly High |
| ESR (1st hour) | 22 mm/hr | 0-15 | H - Elevated |
Interpretation: Low MCV and MCH suggest microcytic hypochromic picture, consistent with iron deficiency or thalassemia trait. However, Hb is normal. Severe thrombocytopenia (platelets 60K) requires urgent evaluation - causes may include ITP, hypersplenism, dengue, or drug-related. Elevated ESR indicates inflammation.
2. LIPID PROFILE
| Parameter | Result | Reference | Flag |
|---|---|---|---|
| Total Cholesterol | 154.29 mg/dL | Desirable <200 | Normal |
| HDL Cholesterol | 37.0 mg/dL | >60 (negative risk) | Low-Normal |
| Triglycerides | 220.0 mg/dL | <150 | 🟠 HIGH |
| LDL Cholesterol | 73.29 mg/dL | Optimal <100 | Normal |
| VLDL Cholesterol | 44 mg/dL | 6-38 | H - High |
| TC/HDL Ratio | 4.17 | 3.5-5.0 | Normal |
| Non-HDL Cholesterol | 117.29 mg/dL | <160 | Normal |
Interpretation: Isolated hypertriglyceridaemia (220 mg/dL) with elevated VLDL - consistent with poor glycaemic control (diabetes). LDL is well-controlled. HDL is borderline low, which is a cardiovascular risk factor.
3. THYROID PROFILE
| Parameter | Result | Reference | Flag |
|---|---|---|---|
| T3 (Total) | 1.25 ng/mL | 0.70-1.81 | Normal |
| T4 (Total) | 8.66 mg/dL | 5.0-12.6 | Normal |
| TSH (3rd Gen) | 0.859 mIU/mL | 0.35-5.50 | Normal |
Interpretation: Thyroid function is normal (euthyroid).
4. VITAMIN B12
| Parameter | Result | Reference | Flag |
|---|---|---|---|
| Vitamin B12 (Serum) | 478.16 pg/mL | 145-914 | Normal |
Interpretation: Normal B12 levels. No deficiency.
5. VITAMIN D (25-OH)
| Parameter | Result | Reference | Flag |
|---|---|---|---|
| 25-OH Vitamin D | 32.71 ng/mL | Sufficiency: 30-100 | Normal (borderline sufficient) |
Interpretation: Just within the sufficient range (30-100 ng/mL). Marginally adequate - can consider maintaining with dietary sources or supplementation.
6. IRON STUDIES
| Parameter | Result | Reference | Flag |
|---|---|---|---|
| Total Iron | 87.22 mg/dL | 70-180 | Normal |
| TIBC | 325.22 mg/dL | 250-450 | Normal |
| UIBC | 238 µg/dL | 150-345 | Normal |
| Transferrin Saturation | 26.82% | 20-50% | Normal |
Interpretation: Iron stores are normal. This, combined with low MCV/MCH, suggests thalassemia trait rather than iron deficiency anaemia - requires Hb electrophoresis for confirmation.
7. HbA1c & GLUCOSE CONTROL
| Parameter | Result | Reference | Flag |
|---|---|---|---|
| HbA1c | 12.0% | <6.5% | 🔴 Very HIGH |
| Estimated Avg Glucose | 297.70 mg/dL | <140 | 🔴 Very HIGH |
| Fasting Blood Sugar | 275.54 mg/dL | 70-110 | 🔴 Very HIGH |
Interpretation: HbA1c of 12% reflects very poor glycaemic control over the past 3 months. FBS of 275 mg/dL further confirms uncontrolled diabetes. Action is urgently needed - medication review, dietary counselling, and possible intensification of therapy.
8. RENAL FUNCTION TESTS (RFT)
| Parameter | Result | Reference | Flag |
|---|---|---|---|
| Blood Urea | 44.87 mg/dL | 15-46 | Normal |
| BUN | 20.89 mg/dL | 7-25 | Normal |
| Serum Creatinine | 1.13 mg/dL | 0.70-1.40 | Normal |
| BUN/Creatinine Ratio | 18.49 | 9.1-23.1 | Normal |
| Uric Acid | 5.7 mg/dL | 3.5-7.2 | Normal |
| Calcium | 8.85 mg/dL | 8.5-10.6 | Normal |
| Sodium | 137.3 mEq/L | 136-146 | Normal |
| Potassium | 4.22 mEq/L | 3.5-5.5 | Normal |
| Chloride | 100.32 mEq/L | 96-108 | Normal |
| eGFR | 80 mL/min/1.73m² | >90 | 🟡 Mildly Reduced |
Interpretation: eGFR of 80 indicates CKD Stage G2 (mildly reduced kidney function) - needs monitoring, especially given uncontrolled diabetes which accelerates nephropathy.
9. LIVER FUNCTION TEST (LFT) with GGT
| Parameter | Result | Reference | Flag |
|---|---|---|---|
| Bilirubin Total | 0.60 mg/dL | 0.2-1.0 | Normal |
| Bilirubin Direct | 0.22 mg/dL | 0-0.6 | Normal |
| SGOT (AST) | 16.53 IU/L | <40 | Normal |
| SGPT (ALT) | 25.61 IU/L | <41 | Normal |
| ALP | 134.02 U/L | 0-150 | Normal |
| Total Protein | 6.63 g/dL | 6.4-8.2 | Normal |
| Albumin | 3.55 g/dL | 3.4-5.0 | Normal |
| Globulin | 3.08 g/dL | 1.8-3.8 | Normal |
| A/G Ratio | 1.15 | 0.9-1.8 | Normal |
| GGT | 55.51 U/L | 12-64 | Normal |
Interpretation: Liver function is entirely within normal limits.
10. SEROLOGY
| Parameter | Result |
|---|---|
| CRP (C-Reactive Protein) | Negative |
| RA Factor | Negative |
Interpretation: No acute inflammation marker (CRP negative) and no rheumatoid factor.
SUMMARY OF KEY CONCERNS
| Priority | Finding | Action Needed |
|---|---|---|
| 🔴 URGENT | HbA1c 12.0% + FBS 275 mg/dL | Urgent diabetes management review - medication adjustment, dietician referral |
| 🔴 URGENT | Platelet count 60K (Thrombocytopenia) | Urgent haematology review - rule out ITP, dengue, hypersplenism, drug cause |
| 🟠 HIGH | Hypertriglyceridaemia (220 mg/dL) | Dietary modification; likely to improve with better glucose control |
| 🟡 MONITOR | eGFR 80 (CKD G2) | Regular monitoring; tight glucose & BP control to prevent progression |
| 🟡 MONITOR | Low MCV/MCH with normal iron | Consider Hb electrophoresis to rule out thalassemia trait |
| 🟡 WATCH | HDL 37 mg/dL (borderline low) | Lifestyle modifications - exercise, diet |
| ✅ NORMAL | Thyroid, B12, Vitamin D, LFT, electrolytes | No action needed |
Disclaimer: This is a summary of laboratory findings. All results should be interpreted in clinical context by a qualified physician. This summary does not constitute medical advice or a diagnosis.
Find recent research on thrombocytopenia in diabetes patients
Searching PubMed
thrombocytopenia diabetes mellitus
Searching PubMed
platelet count diabetes mellitus type 2
Searching the Web
thrombocytopenia in type 2 diabetes mellitus mechanisms recent research 2024 2025
Reading Article
Reading Article
Reading Article
Searching PubMed
immune thrombocytopenia ITP diabetes mellitus comorbidity
Reading Web Page
thrombocytopenia diabetes mellitus mechanisms platelet count
Reading Article
Reading Article
Searching PubMed
low platelet count hyperglycemia HbA1c poor glycemic control
Reading Article
Reading Article
Here is a synthesis of the recent research on thrombocytopenia and platelet abnormalities in diabetes, directly relevant to Mr. Hari Dev Kumar's findings.
Recent Research: Thrombocytopenia & Platelet Abnormalities in Diabetes
1. Overview: How Diabetes Affects Platelets
Research consistently shows diabetes affects platelets in two key directions: platelet hyperactivation (more common) and, in a subset of patients, thrombocytopenia (low count). These are related but distinct problems.
2. Platelet Indices & Glycaemic Control (2024-2025)
Khungala et al. (2025) - J Pharm Bioallied Sci | PMID: 41523002
A cross-sectional study of 90 T2DM patients vs. 30 controls, stratified by HbA1c (good vs. moderate vs. poor control):
- Mean Platelet Volume (MPV) was significantly higher in poorly-controlled diabetics (11.2 fL) vs. well-controlled ones (9.4 fL)
- HbA1c correlated positively with MPV (r = 0.42, p = 0.01)
- High MPV + high neutrophil-to-lymphocyte ratio (NLR) together indicate platelet hyperactivity and chronic low-grade inflammation
Relevance to Hari Dev Kumar: His MPV is 12.1 fL (high) with HbA1c of 12% - this fits exactly the pattern of poor glycaemic control driving platelet abnormalities.
Liu et al. (2024) - Clinical Laboratory | PMID: 38213227
In T2DM patients, elevated MPV and PDW (platelet distribution width) were correlated with:
- Dyslipidaemia (elevated TG, low HDL-C)
- Coagulation dysfunction (elevated vWF and PAI-1)
- Systemic inflammation (elevated IL-6, TNF-alpha)
This establishes a clear inflammatory-metabolic-platelet axis in T2DM - all three are present in this patient (high TG, borderline HDL, elevated ESR).
Medeiros et al. (2025) - World J Diabetes | PMID: 40548285
This editorial highlights that platelet indices (MPV, PDW) may serve as accessible markers to predict poor glucoregulation in T2DM patients. The pathophysiology involves:
- Prolonged hyperglycaemia increasing advanced glycation end-products (AGEs)
- AGEs activating platelet surface receptors
- Chronic systemic inflammation impairing normal megakaryopoiesis (platelet production)
3. Haematological Changes in Diabetes - Broad Review (2024)
Mbah et al. (2024) - Cureus | PMID: 39130996
This literature review confirmed that across multiple studies in T2DM:
- Platelet counts show varied alterations - some studies show lower counts, others higher MPV with compensatory lower counts
- WBC negatively correlated with HDL-C (r = -0.75)
- RBC indices (MCV, MCH) negatively correlate with total cholesterol
- The pattern of HbA1c as an index of glucose control was identified as the best way to track haematological change over time
4. ITP (Immune Thrombocytopenia) + Diabetes - A Clinically Important Overlap
Li et al. (2022) - Br J Haematol | PMID: 35288929
A retrospective cohort study of 458 ITP patients found:
- 7.6% of ITP patients had pre-existing T2DM
- Diabetic patients with ITP had a higher response rate to therapy (71%) vs. non-diabetics (53%)
- When metformin was included, response rate reached 88%
- Conclusion: metformin has immunomodulatory properties that may benefit ITP in diabetic patients
Hou et al. (2026) - Br J Haematol | PMID: 39696781
The most recent and directly actionable study - a multicentre propensity score-matched trial (57 patients per arm):
- Compared corticosteroids alone vs. corticosteroids + metformin for newly-diagnosed ITP patients with pre-existing T2DM
- The metformin group had a significantly higher sustained response rate and longer duration of response
- Metformin's immunomodulatory mechanism (AMPK activation, T-regulatory cell enhancement) appears to suppress the autoimmune platelet destruction
- Corticosteroids alone worsen hyperglycaemia in T2DM - adding metformin addresses both problems simultaneously
5. Inflammation Indices & Microvascular Complications (2024)
Li et al. (2024) - Front Endocrinol | PMID: 38660516
In 1,058 T2DM patients, the platelet-to-lymphocyte ratio (PLR) and systemic immune-inflammation index (SII) were significantly associated with:
- Diabetic nephropathy (OR 1.60)
- Diabetic retinopathy (OR 1.55)
With an eGFR of 80 (CKD G2) and HbA1c of 12%, this patient is at high risk for microvascular complications that compound the platelet/haematological picture.
Key Takeaways Relevant to This Patient
| Research Finding | Implication for Hari Dev Kumar |
|---|---|
| High MPV correlates with poor HbA1c (Khungala 2025) | MPV 12.1 + HbA1c 12% - consistent with research pattern |
| Platelet indices linked to inflammation + dyslipidaemia (Liu 2024) | His elevated TG, raised ESR, elevated MPV form a recognized triad |
| ITP-T2DM overlap exists (7.6% prevalence in ITP) | Immune thrombocytopenia must be ruled out - platelet 60K is severe |
| Metformin improves ITP outcomes in T2DM patients (Hou 2026) | If ITP is confirmed, metformin may serve dual purpose |
| PLR/SII predict microvascular complications (Li 2024) | Nephropathy monitoring is warranted given eGFR 80 + HbA1c 12% |
Bottom line from current evidence: The thrombocytopenia (platelets 60K) in this patient requires urgent haematological work-up. While diabetes can drive platelet dysfunction and mildly alter counts via chronic inflammation and poor glycaemic control, a platelet count as low as 60K is not explained by hyperglycaemia alone - ITP, hypersplenism, dengue serology, or drug-induced thrombocytopenia should all be evaluated. The very recent 2026 evidence (Hou et al.) also suggests that if ITP is confirmed, combining metformin (which he likely already needs for T2DM management) with steroids is a promising strategy.
This is a shared conversation. Sign in to Orris to start your own chat.